Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB-IIB cervical carcinoma: A retrospective study of 288 patients

Journal of Surgical Oncology

Volumn 104, Issue 5, 2011, Pages 480-485

  Zheng, Min ^a   Huang, Long ^a   Liu, Ji Hong ^a   Xiong, Ying ^a   Li, Jun Dong ^a   Huang, Xin ^a   He, Li ^a   Ren, Yu Feng ^a   Wang, Hui Yun ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

cervical carcinoma; PLNM; prognostic factors; type II radical hysterectomy

Indexed keywords

BLEOMYCIN; CISPLATIN; FLUOROURACIL; IFOSFAMIDE; PACLITAXEL;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLOOD VESSEL INJURY; CANCER RADIOTHERAPY; CANCER STAGING; CYSTIC LYMPHANGIOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYDROURETER; LEG EDEMA; LYMPH NODE METASTASIS; LYMPHEDEMA; MAJOR CLINICAL STUDY; MORBIDITY; OVERALL SURVIVAL; PELVIC LYMPH NODE METASTASIS; PELVIS LYMPHADENECTOMY; PERIOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADICAL HYSTERECTOMY; RECTUM DISEASE; RECTUM HEMORRHAGE; RETROSPECTIVE STUDY; RISK FACTOR; URETER INJURY; URINARY TRACT DISEASE; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; IFOSFAMIDE; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PACLITAXEL; PELVIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 80052468471     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21956     Document Type: Article

References (24)

1. Chi DS, Lanciano RM, Kudelka AP:, Cervical cancer. In:, Pazdur R, Coia LR, Hoskins WJ, Wagman LD, editors. In cancer management: A multidisciplinary approach medical, surgical, radiation oncology, 5th edition New York: PRR Inc; 2001. pp. 359-384.
2. Parkin DM, Bray F, Ferlay J, et al.: Global cancer statistics, 2002. A Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
3. Landoni F, Maneo A, Lolombo A, et al.: Randomized study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997; 350: 535-540. (Pubitemid 27348428)
4. Peters WA, Liu PY, Barrett RJ, et al.: Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000; 18: 1606-1613. (Pubitemid 30220538)
5. Zheng M, Huang L, He L, et al.: Evaluation of the effects of type II radical hysterectomy in the treatment of 960 patients with stage IB-IIB cervical carcinoma: A retrospective study. J Surg Oncol 2010; 9999: 1-7. DOI 10.1002/jso.21800
6. Shingleton HM, Jones WB, Russell A, et al.: Hysterectomy in invasive cervical cancer: A national patterns of care study of the American College of Surgeons. J Am Coll Surg 1996; 183: 393-400. (Pubitemid 26332754)
7. Cheng X, Cai SM, Li ZT, et al.: The prognosis of women with stage IB1-IIB node-positive cervical carcinoma after radical surgery. World J Surg Oncol 2004; 18: 47.
8. Aoki Y, Sasaki M, Watanabe M, et al.: High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecol Oncol 2000; 77: 305-309. (Pubitemid 30317154)
9. Monk BJ, Cha DS, Walker JL, et al.: Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma. Gynecol Oncol 1994; 54: 4-9. (Pubitemid 24239400)
10. Hopkins MP, Morley GW:, Stage Ib squamous cell cancer of the cervix: Clinicopathologic features related to survival. Am J Obstet Gynecol 1991; 164: 1520-1527.
11. Hsu CT, Cheng YS, Su SC:, Prognosis of uterine cervical cancer with extensive lymph node metastases: Special emphasis on the value of pelvic lymphadenectomy in the surgical treatment of uterine cervical cancer. Am J Obstet Gynecol 1972; 114: 954-962.
12. Inoue T, Morita K:, The prognostic significance of number of positive nodes in cervical carcinoma stage Ib, IIa, IIb. Cancer 1990; 65: 1923-1927. (Pubitemid 20147629)
13. Lanza A, Re A, Daddato F, et al.: Treatment failure in cervical cancer: High risk features of relapse. Eur J Gynaecol Oncol 1989; 10: 326-336. (Pubitemid 19234469)
14. Kasamatsu T, Onda T, Sawada M, et al.: Radical hysterectomy for FIGO stage I-IIB adenocarcinoma of the uterine cervix. Br J Cancer 2009; 100: 1400-1405.
15. Piver MS, Rutledge F, Smith JP:, Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 1974; 44: 265-272.
16. Pikaart DP, Holloway RW, Ahmad S, et al.: Clinical-pathologic and morbidity analyses of Types 2 and 3 abdominal radical hysterectomy for cervical cancer. Gynecol Oncol 2007; 107: 205-210. (Pubitemid 47575729)
17. Cai HB, Chen HZ, Zhou YF, et al.: Class II radical hysterectomy in low-risk IB squamous cell carcinoma of cervix: A safe and effective option. Int J Gynecol Canc 2009; 19: 46-49.
18. Piver MS, Lee JY:, The 21st century role of Piver type II hysterectomy in FIGO stage IA, IB cervical cancer: A personal perspective. Eur J Gynaecol Oncol 2008; 29: 109-113. (Pubitemid 351498390)
19. Piura B, Rabinovich A, Friger M:, Number and distribution of pelvic lymph nodes and effect of surgical pathologic factors on pelvic lymph node status in patients with early-stage cervical carcinoma treated with radical hysterectomy and pelvic lymph node dissection. Eur J Gynaecol Oncol 2006; 27: 463-466.
20. Kodama J, Seki N, Ojima Y, et al.: Prognostic factors in node-positive patients with stage IB-IIB cervical cancer treated by radical hysterectomy and pelvic lymphadenectomy. Int J Gynaecol Obstet 2006; 93: 130-135.
21. Puente R, Guzman S, Israel E, et al.: Do the pelvic lymph nodes predict the parametrial status in cervical cancer stages IB-IIA ? Int J Gynecol Canc 2004; 14: 832-840. (Pubitemid 39238167)
22. Sakuragi N:, Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer. Int J Clin Oncol 2007; 12: 165-175. (Pubitemid 46944641)
23. Buekers TE, Anderson B, Sorosky JI, et al.: Ovarian function after surgical treatment for cervical cancer. Gynecol Oncol 2001; 80: 85-88. (Pubitemid 32062094)
24. Newton M:, Radical hysterectomy or radiotherapy for stage I cervical cancer. Am J Obstet Gynecol 1975; 123: 535-542.